Results 1 to 10 of about 934,351 (287)

Comparison of euploidy rates between progestin-primed ovarian stimulation and GnRH antagonist protocols: a single-center study in a mixed-ethnicity population. [PDF]

Front Endocrinol (Lausanne)
Ingold C, Dos Santos GG, Barbosa CP, De Oliveira R.   +3 more
europepmc   +1 more source

Ovarian stimulation toward oocyte cryopreservation for fertility preservation in a patient with Hirata syndrome: a clinical challenge in assisted reproduction. [PDF]

Arch Gynecol Obstet
Karkalemis K, Papadopoulou-Marketou N, Kalampokas E, Simopoulou M, Kalampokas T.   +4 more
europepmc   +1 more source

Progesterone Primed Ovarian Stimulation (PPOS) vs. clomiphene Primed Ovarian Stimulation (CPOS) in high responder (HR) patients undergoing controlled ovarian stimulation. A Randomised Control trial. [PDF]

JBRA Assist Reprod
Chaitanya KM, Rao DG, Gambhir I.
europepmc   +1 more source

Impact of COVID-19 infection on laboratory and clinical outcomes of ovarian stimulation using antagonist protocol. [PDF]

Front Med (Lausanne)
Yan Y, Guo M, Chen X, Zhang Q, Wang L, Zhang M, Wang M, Li W, Tao Y.   +8 more
europepmc   +1 more source

Single-cell analysis of follicular fluid reveals dysregulation of ovulatory immune function in Polycystic Ovary Syndrome patients undergoing ovarian stimulation†. [PDF]

Biol Reprod
Wegrzynowicz AK, Banerjee S, Grimes E, Huddleston R, Leyva Jaimes F, Cooney LG, Stanic AK.   +6 more
europepmc   +1 more source

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France. [PDF]

Pharmacoecon Open
Hamamah S, Carette J, Leleu H, Markert M.   +3 more
europepmc   +1 more source

Serum anti-Müllerian hormone and ovarian stimulation parameters in women with polycystic ovary syndrome undergoing assisted reproductive technology: A cross-sectional study. [PDF]

Int J Reprod Biomed
Hosseini S, Salehpour S, Amiresmaili N, Meshkat M, Karimi F.   +4 more
europepmc   +1 more source

A point-of-care assay for genotyping women prior to ovarian stimulation with recombinant or human menopausal gonadotropins in assisted reproduction. [PDF]

Front Endocrinol (Lausanne)
Nilsson M, Hjelmér I, Prahl A, Nenonen H, Lundberg Giwercman Y.   +4 more
europepmc   +1 more source

Predicting the optimal timing for triggering in controlled ovarian stimulation: mature oocytes retrieval predictor. [PDF]

Reprod Biol Endocrinol
Kobanawa M.
europepmc   +1 more source

The role of recombinant LH in ovarian stimulation: what's new? [PDF]

Reprod Biol Endocrinol
Alviggi C, Vigilante L, Cariati F, Conforti A, Humaidan P.   +4 more
europepmc   +1 more source